Ely Benaim

2015

In 2015, Ely Benaim earned a total compensation of $1.2M as Chief Medical Officer at Rexahn Pharmaceuticals.

Compensation breakdown

Bonus$50,000
Non-Equity Incentive Plan$61,875
Option Awards$606,590
Salary$343,750
Other$96,586
Total$1,158,801

Benaim received $606.6K in option awards, accounting for 52% of the total pay in 2015.

Benaim also received $50K in bonus, $61.9K in non-equity incentive plan, $343.8K in salary and $96.6K in other compensation.

Rankings

In 2015, Ely Benaim's compensation ranked 7,229th out of 13,638 executives tracked by ExecPay. In other words, Benaim earned more than 47.0% of executives.

ClassificationRankingPercentile
All
7,229
out of 13,638
47th
Division
Manufacturing
2,719
out of 5,190
48th
Major group
Chemicals And Allied Products
974
out of 1,854
48th
Industry group
Drugs
782
out of 1,528
49th
Industry
Pharmaceutical Preparations
611
out of 1,182
48th
Source: SEC filing on February 24, 2017.

Benaim's colleagues

We found three more compensation records of executives who worked with Ely Benaim at Rexahn Pharmaceuticals in 2015.

2015

Peter Suzdak

Rexahn Pharmaceuticals

Chief Executive Officer

2015

Tae Jeong

Rexahn Pharmaceuticals

Chief Financial Officer

2015

Rakesh Soni

Rexahn Pharmaceuticals

Chief Operating Officer

News

In-depth

You may also like